$1.1 Billion is the total value of SABBY MANAGEMENT, LLC's 161 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 79.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | BRISTOL MYERS SQUIBB COput | $212,531,000 | +0.8% | 34,682 | +4.9% | 19.36% | +40.5% | |
| Sell | MERCK & CO INCcall | $102,535,000 | -63.7% | 18,222 | -58.7% | 9.34% | -49.4% | |
| Buy | BLUEBIRD BIO INCcall | $75,693,000 | +40.2% | 4,250 | +8.1% | 6.89% | +95.4% | |
| New | ISHARES RUSSELL 2000call | $64,109,000 | – | 4,205 | +100.0% | 5.84% | – | |
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $57,101,000 | -8.9% | 931,807 | -5.2% | 5.20% | +27.0% |
| New | SPDR S&P 500call | $53,558,000 | – | 3,000 | +100.0% | 4.88% | – | |
| Buy | ASTRAZENECA PLCcall | $51,863,000 | +241.0% | 14,946 | +232.9% | 4.72% | +375.2% | |
| Buy | SAREPTA THERAPEUTICS INCcall | $50,204,000 | +52.4% | 9,023 | +24.2% | 4.57% | +112.4% | |
| Buy | ASTRAZENECA PLCput | $26,063,000 | +276.5% | 7,511 | +267.6% | 2.37% | +425.2% | |
| Sell | BRISTOL MYERS SQUIBB COcall | $25,891,000 | -4.0% | 4,225 | -0.1% | 2.36% | +33.8% | |
| ODT | New | ODONATE THERAPEUTICS INC | $20,636,000 | – | 825,451 | +100.0% | 1.88% | – |
| Sell | ALNYLAM PHARMACEUTICALS INCput | $20,366,000 | -45.2% | 1,603 | -49.4% | 1.86% | -23.7% | |
| Buy | AMICUS THERAPEUTICS INCcall | $14,924,000 | +139.2% | 10,371 | +150.6% | 1.36% | +233.1% | |
| Sell | MERCK & CO INCput | $14,923,000 | -44.2% | 2,652 | -36.5% | 1.36% | -22.3% | |
| Sell | VERTEX PHARMACEUTICALS INCcall | $13,772,000 | -68.4% | 919 | -67.9% | 1.25% | -55.9% | |
| New | JUNO THERAPEUTICS INCcall | $13,727,000 | – | 3,003 | +100.0% | 1.25% | – | |
| CIGNA CORPcall | $13,607,000 | +8.6% | 670 | 0.0% | 1.24% | +51.5% | ||
| Sell | ZOGENIX INCcall | $12,375,000 | -27.4% | 3,090 | -36.5% | 1.13% | +1.2% | |
| Sell | ALNYLAM PHARMACEUTICALS INCcall | $11,955,000 | -78.3% | 941 | -79.9% | 1.09% | -69.7% | |
| Buy | ESPERION THERAPEUTICS INCput | $10,995,000 | +48.3% | 1,670 | +12.9% | 1.00% | +106.8% | |
| Sell | HALOZYME THERAPEUTICS INCcall | $10,029,000 | -55.7% | 4,950 | -62.0% | 0.91% | -38.3% | |
| Buy | SANGAMO THERAPEUTICS INCcall | $9,906,000 | +65.8% | 6,040 | +51.6% | 0.90% | +130.7% | |
| Buy | INCYTE CORPput | $9,812,000 | +356.8% | 1,036 | +463.0% | 0.89% | +538.6% | |
| ESPR | Buy | ESPERION THERAPEUTICS INC | $9,361,000 | +124.1% | 142,185 | +70.6% | 0.85% | +212.5% |
| New | ALKERMES PLCcall | $8,751,000 | – | 1,599 | +100.0% | 0.80% | – | |
| Sell | BLUEBIRD BIO INCput | $8,638,000 | +11.3% | 485 | -14.2% | 0.79% | +55.2% | |
| Buy | SAREPTA THERAPEUTICS INCput | $8,190,000 | +248.5% | 1,472 | +184.2% | 0.75% | +384.4% | |
| New | ABBVIE INCput | $7,505,000 | – | 776 | +100.0% | 0.68% | – | |
| Sell | VERTEX PHARMACEUTICALS INCput | $7,283,000 | -61.9% | 486 | -61.3% | 0.66% | -46.9% | |
| Buy | IONIS PHARMACEUTICALS INCcall | $7,188,000 | -0.4% | 1,429 | +0.4% | 0.66% | +39.1% | |
| Sell | IONIS PHARMACEUTICALS INCput | $6,187,000 | -24.3% | 1,230 | -23.7% | 0.56% | +5.4% | |
| Sell | SAGE THERAPEUTICS INCcall | $5,765,000 | +31.8% | 350 | -50.1% | 0.52% | +83.6% | |
| ONCE | New | SPARK THERAPEUTICS INC | $5,699,000 | – | 110,827 | +100.0% | 0.52% | – |
| New | SPDR S&P BIOTECHcall | $5,567,000 | – | 656 | +100.0% | 0.51% | – | |
| Buy | INCYTE CORPcall | $5,039,000 | +13.0% | 532 | +39.3% | 0.46% | +57.7% | |
| New | RADIUS HEALTH INCcall | $4,880,000 | – | 1,536 | +100.0% | 0.44% | – | |
| Sell | GW PHARMACEUTICALS PLCput | $4,662,000 | -60.0% | 353 | -69.3% | 0.42% | -44.2% | |
| Buy | SANGAMO THERAPEUTICS INCput | $4,477,000 | +418.8% | 2,730 | +374.8% | 0.41% | +628.6% | |
| Sell | ZOGENIX INCput | $4,462,000 | -0.2% | 1,114 | -12.6% | 0.41% | +39.0% | |
| New | SAGE THERAPEUTICS INCput | $4,266,000 | – | 259 | +100.0% | 0.39% | – | |
| MNKD | New | MANNKIND CORP | $3,357,000 | – | 1,446,900 | +100.0% | 0.31% | – |
| New | NEKTAR THERAPEUTICScall | $3,326,000 | – | 557 | +100.0% | 0.30% | – | |
| GILEAD SCIENCES INCcall | $3,252,000 | -11.6% | 454 | 0.0% | 0.30% | +23.3% | ||
| New | ALEXION PHARMACEUTICALS INCcall | $2,954,000 | – | 247 | +100.0% | 0.27% | – | |
| Buy | AMICUS THERAPEUTICS INCput | $2,878,000 | +281.7% | 2,000 | +300.0% | 0.26% | +434.7% | |
| ONS | Sell | ONCOBIOLOGICS INC | $2,703,000 | -17.2% | 2,079,367 | -12.8% | 0.25% | +15.5% |
| ABBV | New | ABBVIE INC | $2,665,000 | – | 27,559 | +100.0% | 0.24% | – |
| Buy | INTERCEPT PHARMACEUTICALS INCcall | $2,611,000 | +350.2% | 447 | +347.0% | 0.24% | +526.3% | |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $2,446,000 | – | 19,250 | +100.0% | 0.22% | – |
| Sell | AMAG PHARMACEUTICALS INCput | $2,414,000 | -56.4% | 1,822 | -39.3% | 0.22% | -39.2% | |
| VTGN | New | VISTAGEN THERAPEUTICS INC | $2,352,000 | – | 2,115,873 | +100.0% | 0.21% | – |
| VSAR | Buy | VERSARTIS INC | $2,185,000 | +26.1% | 993,100 | +40.4% | 0.20% | +76.1% |
| New | DERMIRA INCput | $2,130,000 | – | 766 | +100.0% | 0.19% | – | |
| HSGX | Buy | HISTOGENICS CORP. | $1,958,000 | +105.2% | 955,060 | +98.3% | 0.18% | +187.1% |
| Buy | MANNKIND CORPput | $1,895,000 | +44.4% | 8,169 | +35.1% | 0.17% | +101.2% | |
| SLNO | New | SOLENO THERAPEUTICS INC | $1,647,000 | – | 915,100 | +100.0% | 0.15% | – |
| New | PROTHENA CORPORATION PLCput | $1,616,000 | – | 431 | +100.0% | 0.15% | – | |
| AMAG | Buy | AMAG PHARMACEUTICALS INC | $1,575,000 | +6.6% | 118,864 | +48.4% | 0.14% | +47.4% |
| APDN | New | APPLIED DNA SCIENCES INC | $1,482,000 | – | 932,350 | +100.0% | 0.14% | – |
| TRXC | New | TRANSENTERIX INC | $1,367,000 | – | 708,097 | +100.0% | 0.12% | – |
| IDXG | New | INTERPACE DIAGNOSTICS GROUP | $1,346,000 | – | 1,319,290 | +100.0% | 0.12% | – |
| Sell | FIBROGEN INCcall | $1,304,000 | -82.5% | 275 | -80.1% | 0.12% | -75.6% | |
| New | ALKERMES PLCput | $1,281,000 | – | 234 | +100.0% | 0.12% | – | |
| MBOT | Sell | MICROBOT MED INC | $1,275,000 | -12.9% | 1,250,000 | -0.1% | 0.12% | +20.8% |
| DERM | New | DERMIRA INC | $1,260,000 | – | 45,304 | +100.0% | 0.12% | – |
| NKTR | New | NEKTAR THERAPEUTICS | $1,194,000 | – | 20,000 | +100.0% | 0.11% | – |
| New | ALEXION PHARMACEUTICALS INCput | $1,148,000 | – | 96 | +100.0% | 0.10% | – | |
| Buy | AXOVANT SCIENCES LTDcall | $1,131,000 | +29.4% | 2,146 | +69.0% | 0.10% | +80.7% | |
| PRQR | New | PROQR THERAPEUTICS N V | $1,120,000 | – | 347,245 | +100.0% | 0.10% | – |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INC | $1,050,000 | – | 300,000 | +100.0% | 0.10% | – |
| HTBX | Buy | HEAT BIOLOGICS INC | $1,001,000 | -10.5% | 2,615,123 | +52.7% | 0.09% | +24.7% |
| Sell | AXOVANT SCIENCES LTDput | $974,000 | -81.6% | 1,848 | -75.9% | 0.09% | -74.2% | |
| Sell | AMARIN CORPORATION PLCcall | $970,000 | -78.1% | 2,418 | -80.9% | 0.09% | -69.6% | |
| New | SYNERGY PHARMACEUTICALS INCcall | $946,000 | – | 4,243 | +100.0% | 0.09% | – | |
| XENE | Buy | XENON PHARMACEUTICALS INC | $931,000 | +2.6% | 329,400 | +7.1% | 0.08% | +44.1% |
| New | AGENUS INCcall | $932,000 | – | 2,860 | +100.0% | 0.08% | – | |
| PRTA | New | PROTHENA CORPORATION PLC | $927,000 | – | 24,730 | +100.0% | 0.08% | – |
| Sell | PROTHENA CORPORATION PLCcall | $900,000 | -86.1% | 240 | -76.0% | 0.08% | -80.6% | |
| CHEK | Sell | CHECK CAP LTD | $876,000 | -58.7% | 1,007,494 | -15.0% | 0.08% | -42.4% |
| New | BIOGEN INCput | $879,000 | – | 230 | +100.0% | 0.08% | – | |
| IPCI | New | INTELLIPHARMACEUTICS INTERNATIONAL INC | $867,000 | – | 1,083,637 | +100.0% | 0.08% | – |
| TESARO INCput | $862,000 | -35.8% | 104 | 0.0% | 0.08% | -10.2% | ||
| ONTX | Sell | ONCONOVA THERAPEUTICS INC | $842,000 | -41.4% | 561,163 | -33.3% | 0.08% | -18.1% |
| OVAS | Buy | OVASCIENCE INC | $840,000 | +7.6% | 600,000 | +9.1% | 0.08% | +49.0% |
| New | AIMMUNE THERAPEUTICS INCput | $840,000 | – | 222 | +100.0% | 0.08% | – | |
| CTXR | New | CITIUS PHARMACEUTICALS INC | $820,000 | – | 210,131 | +100.0% | 0.08% | – |
| TSRO | Buy | TESARO INC | $804,000 | +77.9% | 9,700 | +177.1% | 0.07% | +143.3% |
| New | ESPERION THERAPEUTICS INCcall | $757,000 | – | 115 | +100.0% | 0.07% | – | |
| CPST | New | CAPSTONE TURBINE CORP. | $758,000 | – | 983,787 | +100.0% | 0.07% | – |
| Buy | AMAG PHARMACEUTICALS INCcall | $733,000 | +56.3% | 553 | +117.7% | 0.07% | +116.1% | |
| BPMX | New | BIOPHARMX CORP | $740,000 | – | 6,713,756 | +100.0% | 0.07% | – |
| FCSC | New | FIBROCELL SCIENCE INC | $733,000 | – | 1,128,588 | +100.0% | 0.07% | – |
| Sell | TESARO INCcall | $704,000 | -45.5% | 85 | -15.0% | 0.06% | -23.8% | |
| GALE | Sell | GALENA BIOPHARMA INC | $687,000 | -27.9% | 2,623,610 | -2.9% | 0.06% | +1.6% |
| EIGR | Sell | EIGER BIOPHARMACEUTICALS INC | $684,000 | -32.8% | 49,000 | -47.0% | 0.06% | -7.5% |
| BIOC | New | BIOCEPT INC | $668,000 | – | 962,265 | +100.0% | 0.06% | – |
| IDRA | Buy | IDERA PHARMACEUTICALS INC | $650,000 | +87.9% | 307,987 | +98.7% | 0.06% | +156.5% |
| AXGT | Sell | AXOVANT SCIENCES LTD | $608,000 | -86.2% | 115,462 | -82.0% | 0.06% | -81.0% |
| Sell | TRANSENTERIX INCput | $589,000 | +20.2% | 3,050 | -11.0% | 0.05% | +68.8% | |
| NSPR | New | INSPIREMD INC | $555,000 | – | 4,321,909 | +100.0% | 0.05% | – |
| LPTX | New | LEAP THERAPEUTICS INC | $558,000 | – | 89,350 | +100.0% | 0.05% | – |
| VICL | New | VICAL ORD SHS | $503,000 | – | 275,090 | +100.0% | 0.05% | – |
| NAOV | New | NANOVIBRONIX INC | $477,000 | – | 101,949 | +100.0% | 0.04% | – |
| SNSS | Sell | SUNESIS PHARMACEUTICALS INC | $461,000 | -2.5% | 125,000 | -48.7% | 0.04% | +35.5% |
| Sell | CLOVIS ONCOLOGY INCcall | $456,000 | -95.0% | 67 | -94.0% | 0.04% | -93.0% | |
| SSKN | Buy | STRATA SKIN SCIENCES INC. | $416,000 | +10.9% | 335,105 | +58.3% | 0.04% | +52.0% |
| Sell | EDAP TMS SAput | $413,000 | -37.7% | 1,440 | -35.3% | 0.04% | -11.6% | |
| YTEN | New | YIELD10 BIOSCIENCE INC | $381,000 | – | 215,250 | +100.0% | 0.04% | – |
| Buy | GALECTIN THERAPEUTICS INCput | $378,000 | +425.0% | 1,131 | +235.6% | 0.03% | +580.0% | |
| BPTH | New | BIO PATH HOLDINGS INC | $371,000 | – | 1,833,449 | +100.0% | 0.03% | – |
| PTI | Sell | PROTEOSTASIS THERAPEUTICS INC | $350,000 | +11.1% | 60,000 | -60.0% | 0.03% | +52.4% |
| New | SUNESIS PHARMACEUTICALS INCcall | $327,000 | – | 885 | +100.0% | 0.03% | – | |
| SNES | New | SENESTECH INC | $315,000 | – | 436,863 | +100.0% | 0.03% | – |
| NURO | Buy | NEUROMETRIX INC | $310,000 | +63.2% | 180,039 | +92.4% | 0.03% | +133.3% |
| ACHILLION PHARMACEUTICALS INCcall | $286,000 | -35.7% | 992 | 0.0% | 0.03% | -10.3% | ||
| RXIIW | RXI PHARMACEUTICALS CORP*w | $273,000 | -23.1% | 2,100,797 | 0.0% | 0.02% | +8.7% | |
| VTVT | Sell | VTV THERAPEUTICS INCcl a | $267,000 | -26.6% | 44,500 | -26.9% | 0.02% | 0.0% |
| Buy | REGENXBIO INCcall | $269,000 | +4.7% | 81 | +3.8% | 0.02% | +41.2% | |
| ONCS | Sell | ONCOSEC MEDICAL INC | $249,000 | -74.3% | 153,137 | -84.8% | 0.02% | -63.5% |
| APDNW | Sell | APPLIED DNA SCIENCES INC*w | $244,000 | -57.6% | 642,289 | -25.1% | 0.02% | -42.1% |
| Sell | ABBVIE INCcall | $242,000 | -99.7% | 25 | -99.8% | 0.02% | -99.6% | |
| ONTXW | Sell | ONCONOVA THERAPEUTICS INC*w | $225,000 | -10.7% | 643,244 | -0.3% | 0.02% | +25.0% |
| AIMT | New | AIMMUNE THERAPEUTICS INC | $213,000 | – | 5,629 | +100.0% | 0.02% | – |
| OPGN | Sell | OPGEN INC | $211,000 | -58.9% | 1,129,867 | -31.9% | 0.02% | -44.1% |
| Buy | GALENA BIOPHARMA INCcall | $199,000 | -7.4% | 7,602 | +25.0% | 0.02% | +28.6% | |
| SGLBW | Buy | SIGMA LABS INC*w | $184,000 | +40.5% | 382,868 | +55.3% | 0.02% | +88.9% |
| CHFS | New | CHF SOLUTIONS INC | $182,000 | – | 52,490 | +100.0% | 0.02% | – |
| ABIO | ARCA BIOPHARMA INC | $138,000 | +25.5% | 100,000 | 0.0% | 0.01% | +85.7% | |
| JAGX | Sell | JAGUAR HEALTH INC | $142,000 | -67.5% | 1,045,741 | -52.2% | 0.01% | -55.2% |
| SPHS | Sell | SOPHIRIS BIO INC | $127,000 | -82.3% | 55,907 | -83.2% | 0.01% | -74.5% |
| RTTR | Sell | RITTER PHARMACEUTICALS INC | $118,000 | -92.8% | 357,781 | -92.3% | 0.01% | -89.7% |
| RDHL | New | REDHILL BIOPHARMA LTDads | $110,000 | – | 21,322 | +100.0% | 0.01% | – |
| New | ANTHERA PHARMACEUTICALS INCput | $109,000 | – | 658 | +100.0% | 0.01% | – | |
| New | AMYRIS INCput | $94,000 | – | 250 | +100.0% | 0.01% | – | |
| ADVAXIS INCcall | $77,000 | -31.9% | 270 | 0.0% | 0.01% | 0.0% | ||
| EGLTQ | Sell | EGALET CORP | $74,000 | -92.0% | 73,792 | -89.8% | 0.01% | -88.3% |
| Buy | SOPHIRIS BIO INCput | $62,000 | +158.3% | 275 | +145.5% | 0.01% | +200.0% | |
| TNDM | New | TANDEM DIABETES CARE INC. | $65,000 | – | 27,487 | +100.0% | 0.01% | – |
| New | NABRIVA THERAPEUTICS PLC | $60,000 | – | 10,000 | +100.0% | 0.01% | – | |
| Buy | FUELCELL ENERGY INCput | $55,000 | +31.0% | 1,236 | +417.2% | 0.01% | +66.7% | |
| New | ACHILLION PHARMACEUTICALS INCput | $50,000 | – | 174 | +100.0% | 0.01% | – | |
| MDGS | Sell | MEDIGUS LTDadr | $48,000 | -91.7% | 36,943 | -85.7% | 0.00% | -89.5% |
| NSPRZ | Buy | INSPIREMD INC*w | $40,000 | 0.0% | 2,003,848 | +0.1% | 0.00% | +33.3% |
| ACHN | New | ACHILLION PHARMACEUTICALS INC | $48,000 | – | 16,705 | +100.0% | 0.00% | – |
| New | AETERNA ZENTARIS INCput | $46,000 | – | 264 | +100.0% | 0.00% | – | |
| New | AGENUS INCput | $38,000 | – | 116 | +100.0% | 0.00% | – | |
| IMMP | New | IMMUTEP LTDadr | $34,000 | – | 21,500 | +100.0% | 0.00% | – |
| CFRX | Sell | CONTRAFECT CORP. | $35,000 | -73.5% | 34,333 | -71.2% | 0.00% | -66.7% |
| NSPRW | Sell | INSPIREMD INC*w | $36,000 | -12.2% | 1,193,470 | -0.1% | 0.00% | 0.0% |
| BNTCW | BENITEC BIOPHARMA LTD*w | $36,000 | +33.3% | 90,193 | 0.0% | 0.00% | +50.0% | |
| New | AVEO PHARMACEUTICALS INCcall | $34,000 | – | 122 | +100.0% | 0.00% | – | |
| New | AETERNA ZENTARIS INCcall | $33,000 | – | 138 | +100.0% | 0.00% | – | |
| OASMY | OASMIA PHARMACEUTICALadr | $17,000 | -15.0% | 19,000 | 0.0% | 0.00% | +100.0% | |
| Sell | MANNKIND CORPcall | $27,000 | -92.8% | 116 | -93.3% | 0.00% | -92.0% | |
| CYTXW | Sell | CYTORI THERAPEUTICS INC*w | $11,000 | -75.6% | 1,028,634 | -16.9% | 0.00% | -66.7% |
| BIOAQ | Sell | BIOAMBER INC | $9,000 | -99.4% | 21,319 | -99.3% | 0.00% | -99.0% |
| IMUCW | Sell | IMMUNOCELLULAR THERAPEUTICS*w | $16,000 | +100.0% | 392,702 | -6.5% | 0.00% | 0.0% |
| ONSIW | Sell | ONCOBIOLOGICS INC*w | $3,000 | -83.3% | 89,644 | -43.4% | 0.00% | -100.0% |
| Exit | CYTRX CORPput | $0 | – | -100 | -100.0% | 0.00% | – | |
| KZIA | New | KAZIA THERAPEUTICS LTDadr | $0 | – | 366,668 | +100.0% | 0.00% | – |
| New | IMMUNOMEDICS INCput | $2,000 | – | 305 | +100.0% | 0.00% | – | |
| ONSIZ | Sell | ONCOBIOLOGICS INC*w | $4,000 | -69.2% | 199,193 | -23.4% | 0.00% | -100.0% |
| FCEL | Exit | FUELCELL ENERGY INC | $0 | – | -11,968 | -100.0% | -0.00% | – |
| Exit | OREXIGEN THERAPEUTICS INCput | $0 | – | -197 | -100.0% | -0.00% | – | |
| OREXQ | Exit | OREXIGEN THERAPEUTICS INC | $0 | – | -19,700 | -100.0% | -0.00% | – |
| EYEG | Exit | EYEGATE PHARMACEUTICALS INC | $0 | – | -46,378 | -100.0% | -0.00% | – |
| ANTH | Exit | ANTHERA PHARMACEUTICALS INC | $0 | – | -52,046 | -100.0% | -0.01% | – |
| Exit | ANTARES PHARMA INCput | $0 | – | -227 | -100.0% | -0.01% | – | |
| Exit | OTONOMY INCcall | $0 | – | -275 | -100.0% | -0.01% | – | |
| RNVA | Exit | RENNOVA HEALTH INC | $0 | – | -466,880 | -100.0% | -0.01% | – |
| Exit | IDERA PHARMACEUTICALS INCcall | $0 | – | -416 | -100.0% | -0.01% | – | |
| CLSN | Exit | CELSION CORP. | $0 | – | -67,403 | -100.0% | -0.01% | – |
| OHRP | Exit | OHR PHARMACEUTICAL INC | $0 | – | -152,127 | -100.0% | -0.01% | – |
| Exit | NEWLINK GENETICS CORPput | $0 | – | -122 | -100.0% | -0.01% | – | |
| GEVO | Exit | GEVO INC | $0 | – | -224,810 | -100.0% | -0.01% | – |
| SGLB | Exit | SIGMA LABS INC | $0 | – | -70,000 | -100.0% | -0.01% | – |
| BVXV | Exit | BIONDVAX PHARMACEUTICALS LTDadr | $0 | – | -19,376 | -100.0% | -0.01% | – |
| APHB | Exit | AMPLIPHI BIOSCIENCES CORP. | $0 | – | -149,248 | -100.0% | -0.01% | – |
| ROSGQ | Exit | ROSETTA GENOMICS LTD | $0 | – | -141,741 | -100.0% | -0.01% | – |
| Exit | VERSARTIS INCcall | $0 | – | -632 | -100.0% | -0.01% | – | |
| ADXS | Exit | ADVAXIS INC | $0 | – | -37,634 | -100.0% | -0.01% | – |
| Exit | ADVAXIS INCput | $0 | – | -414 | -100.0% | -0.01% | – | |
| ROKA | Exit | ROKA BIOSCIENCE INC | $0 | – | -237,322 | -100.0% | -0.01% | – |
| CHFS | Exit | CHF SOLUTIONS INC | $0 | – | -367,893 | -100.0% | -0.01% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -4,726 | -100.0% | -0.02% | – |
| Exit | MEDICINES COcall | $0 | – | -66 | -100.0% | -0.02% | – | |
| NTLA | Exit | INTELLIA THERAPEUTICS INC | $0 | – | -11,281 | -100.0% | -0.02% | – |
| Exit | ADAMIS PHARMACEUTICALS INCput | $0 | – | -574 | -100.0% | -0.02% | – | |
| Exit | ANTARES PHARMA INCcall | $0 | – | -1,016 | -100.0% | -0.02% | – | |
| CRMD | Exit | CORMEDIX INC | $0 | – | -648,955 | -100.0% | -0.02% | – |
| Exit | CYTOKINETICS INCput | $0 | – | -237 | -100.0% | -0.02% | – | |
| Exit | AERIE PHARMACEUTICALS INCput | $0 | – | -74 | -100.0% | -0.02% | – | |
| RNN | Exit | REXAHN PHARMACEUTICALS INC | $0 | – | -169,901 | -100.0% | -0.03% | – |
| STML | Exit | STEMLINE THERAPEUTICS INC | $0 | – | -43,749 | -100.0% | -0.03% | – |
| ADMP | Exit | ADAMIS PHARMACEUTICALS INC | $0 | – | -100,378 | -100.0% | -0.03% | – |
| CDTX | Exit | CIDARA THERAPEUTICS INC | $0 | – | -64,300 | -100.0% | -0.03% | – |
| KRYS | Exit | KRYSTAL BIOTECH INC | $0 | – | -53,558 | -100.0% | -0.04% | – |
| VXZ | Exit | BARCLAYS BANK PLCipath | $0 | – | -26,500 | -100.0% | -0.04% | – |
| RIBT | Exit | RICEBRAN TECHNOLOGIES | $0 | – | -442,033 | -100.0% | -0.04% | – |
| Exit | FLEXION THERAPEUTICS INCput | $0 | – | -292 | -100.0% | -0.05% | – | |
| Exit | FLEXION THERAPEUTICS INCcall | $0 | – | -341 | -100.0% | -0.05% | – | |
| SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -533,563 | -100.0% | -0.05% | – |
| EKSO | Exit | EKSO BIONICS HOLDINGS INC | $0 | – | -702,364 | -100.0% | -0.06% | – |
| Exit | STEMLINE THERAPEUTICS INCcall | $0 | – | -802 | -100.0% | -0.06% | – | |
| Exit | GLOBAL BLOOD THERAPEUTICS INCcall | $0 | – | -301 | -100.0% | -0.06% | – | |
| CVM | Exit | CEL SCI CORP. | $0 | – | -587,822 | -100.0% | -0.06% | – |
| Exit | NEWLINK GENETICS CORPcall | $0 | – | -1,000 | -100.0% | -0.07% | – | |
| TROV | Exit | TROVAGENE INC | $0 | – | -1,689,778 | -100.0% | -0.08% | – |
| ATNM | Exit | ACTINIUM PHARMACEUTICALS INC. | $0 | – | -2,434,103 | -100.0% | -0.09% | – |
| WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -75,000 | -100.0% | -0.11% | – |
| KDMN | Exit | KADMON HOLDINGS INC | $0 | – | -525,695 | -100.0% | -0.12% | – |
| DMPI | Exit | DELMAR PHARMACEUTICALS INC. | $0 | – | -2,121,202 | -100.0% | -0.12% | – |
| Exit | IMMUNOMEDICS INCcall | $0 | – | -1,322 | -100.0% | -0.12% | – | |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -42,646 | -100.0% | -0.15% | – |
| Exit | PTC THERAPEUTICS INCcall | $0 | – | -1,277 | -100.0% | -0.17% | – | |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -28,517 | -100.0% | -0.19% | – |
| Exit | SEATTLE GENETICS INCcall | $0 | – | -542 | -100.0% | -0.19% | – | |
| Exit | FIVE PRIME THERAPEUTICS INCput | $0 | – | -758 | -100.0% | -0.20% | – | |
| Exit | INSMED INCcall | $0 | – | -1,375 | -100.0% | -0.28% | – | |
| Exit | CYTOKINETICS INCcall | $0 | – | -3,398 | -100.0% | -0.32% | – | |
| Exit | INSMED INCput | $0 | – | -1,851 | -100.0% | -0.38% | – | |
| Exit | UNITED THERAPEUTICS CORPcall | $0 | – | -542 | -100.0% | -0.42% | – | |
| Exit | DBV TECHNOLOGIES SAput | $0 | – | -1,784 | -100.0% | -0.50% | – | |
| Exit | SEATTLE GENETICS INCput | $0 | – | -1,734 | -100.0% | -0.62% | – | |
| Exit | KITE PHARMA INCput | $0 | – | -543 | -100.0% | -0.64% | – | |
| Exit | DBV TECHNOLOGIES SAcall | $0 | – | -10,908 | -100.0% | -3.02% | – | |
| Exit | ISHARES RUSSELL 2000put | $0 | – | -5,980 | -100.0% | -5.79% | – | |
| Exit | SPDR S&P 500 ETFput | $0 | – | -5,000 | -100.0% | -8.21% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2018-02-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
| ISHARES TR | 35 | Q3 2023 | 52.2% |
| SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
| AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
| BIOGEN INC | 24 | Q1 2021 | 26.2% |
| SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
| BIOGEN INC | 23 | Q1 2021 | 13.7% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
| BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
| VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
| Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
| Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
| Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
| HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
| PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
| Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
| TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
| Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
| TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.